DOACs and Reversal in High-Risk Situations - SCIENTIFIC FACULTY ROOM. ISTH Academy. Presenters F. Apr 14 2021; 318216

(0)

You must be signed in to access your cart

Create Account Sign In

Home

not display
Featured
Webinars
Events
eLearning & CME
Topics
Industry portal
Journals
Open access
FXI Inhibitors

Search Loading

Navbar input

WAIT FOR SUGGESTIONS BY CATEGORY
OR CONTINUE TYPING IN YOUR KEYWORDS

ENTER ONE OR MULTIPLE KEYWORDS &
PRESS THE SEARCH BUTTON
From

To
Search

Favorites
Advanced Minimize

More ▾ Less ▸

Clear

DOACs and Reversal in High-Risk Situations - SCIENTIFIC FACULTY ROOM

ISTH Academy. Presenters F. 04/14/21; 318216

Faculty / Presenters

CLICK HERE TO LOGIN
REGULAR CONTENT

Login now to access Regular content available to all registered users.

Access to Premium content is currently a membership benefit.

Click here to join ISTH or renew your membership.

Apple

Google (online)

Office 365 (online)

Outlook

Outlook.com (online)

Yahoo

318216

Discussion Forum (0)

Rate & Comment (0)

Code of conduct/disclaimer available in General Terms & Conditions

Trending Content

Rebalancing Therapies for Hemophilia: Are You Ready?

Shapiro A, Croteau S, Bisson E. Feb 26, 2025

Factor XI/XIa Inhibition as a Target for Anticoagulation: The What, Why, and How

Weitz J, Gailani D, Connors J. Sep 11, 2024

Factor XI/XIa Inhibition: Ensuring Safety and Efficacy

Weitz J, Al-Lamee R, Johnston C. Nov 12, 2024

Thromboprophylaxis in Pregnant Patients

Archibald W, Middeldorp S, Casais P. Mar 5, 2025

Treating ITP: Working Together to Improve Outcomes

Cooper N, Kuter D, Gernsheimer T. Nov 15, 2024

Anticoagulation in Patients with Chronic Kidney Disease

Tham D, Swan D, Kiskaddon A. Jan 29, 2025

Anticoagulation for stroke prevention in AFib and treatment of VTE and PVT in cirrhosis

Afzal A, Carlin S, Roberts L. Oct 15, 2024

Monitoring and Reversal for Factor Xa Inhibitors

Xu Y, Montalvao S, Campello E. Oct 30, 2024

SSC on the Case: The Influence of Aging on von Willebrand Disease: Challenges and Considerations

Baker R, James P, Leebeek F, Connell N. Mar 20, 2025

Using AI to Predict or Guide Diagnosis/Treatment

Lam B, Sivapalaratnam S, Patell R. May 7, 2025

New Insights in Diagnosis and Treatment of Antiphospholipid Syndrome

Parks A, Amigo M, Woller S. Jul 31, 2024

Advancing Care: Navigating the ISTH Hemophilia Clinical Practice Guidelines

DiMichele D, Rezende S, O'Connell N. Sep 5, 2024

Gene Therapy in Hemophilia: Clinical Care Strategies for Gene Therapy

Peyvandi F, La Mura V, Moro M. Oct 2, 2024

Case Consult: Optimizing the Management of cTTP

Cataland S, Chaturvedi S, Scully M. Nov 19, 2024

SSC on the Case: Platelet Immunology: Heavy Menstrual Bleeding in Patients with Immune Thrombocytopenia

Al-Samkari H, Nazy I, Lambert M, Sharma R. Apr 15, 2025

Emerging Therapies in Thrombosis Initiative Supporters Corner

Presenters F. Jun 21, 2024

Research Round-Up: Exploring the Future of Balancing Bleeding and Clotting Risk in Factor XI/XIa

Wang T, Bahit C, Coutinho J, Winkelmayer W. Sep 4, 2024

SSC on the Case: Pediatric and Neonatal Thrombosis and Hemostasis: CSVT and Mesenteric Vein Thrombosis with MIS-C

Barg A, Zia A, Whitworth H, David J, Mak C. Feb 10, 2025

Acquired Hemophilia A: Emicizumab as Treatment?

Al Housni Z, Kruse-Jarres R, Knoebl P. Aug 20, 2024

Incidence of thrombotic events in the fitusiran clinical development program

Young G. Jun 24, 2024

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).
USER TERMS AND CONDITIONS | PRIVACY POLICY

Cookie Settings
Accept Terms & all Cookies

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.

Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.

Google Analytics & Google Tag Manager embedded tracking functionalities

Google Analytics and Google Tag Manager embedded tracking functionalities are used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG's features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.